Trending
November 19, 2024 Georgiamune Appoints Mark Avagliano as Chief Business OfficerNovember 14, 2024 myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma PatientsNovember 12, 2024 Avalo Therapeutics Closes $69.4 Million FinancingNovember 7, 2024 Aurinia Pharmaceuticals Appoints Craig Johnson to Board of DirectorsNovember 4, 2024 Alexandria Venture Investments Join $10M Seed Financing For CrossBridge Bio
Featured
November 19, 2024
Georgiamune Appoints Mark Avagliano as Chief Business Officer
GAITHERSBURG, Md., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage... Read more »
November 14, 2024
myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma Patients
Boston-based myBiometry, which is developing a device to help patients with asthma and chronic obstructive pulmonary... Read more »
November 12, 2024
Avalo Therapeutics Closes $69.4 Million Financing
WAYNE, Pa. and ROCKVILLE, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical... Read more »
